Skip to main content
padlock icon - secure page this page is secure

Fixed erythrodysaesthesia plaque due to intravenous injection of docetaxel

Buy Article:

$52.00 + tax (Refund Policy)

Docetaxel (Taxotere®), a semisynthetic taxoid, acts as an antimicrotubule agent and is considered to have great potential in the treatment of non-small cell lung cancer, advanced breast cancer, ovarian cancer and some other tumours. Well-recognized side-effects include dose-limiting neutropenia, fluid retention, myalgia, neuropathy, hypersensitivity reaction, alopecia, mucositis, nail changes and cutaneous reactions such as acral erythema. We describe a unique docetaxel-induced cutaneous reaction presenting as fixed erythematous plaque(s) unrelated to extravasation or previous skin injury; histopathological studies were performed in three of the four cases.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: Taxotere®; adverse drug reaction; docetaxel; erythrodysaesthesia

Document Type: Research Article

Affiliations: 1: Departments of Dermatology and 2: Oncology, National Taiwan University Hospital, 7 Chung-Shan South Road, Taipei, Taiwan

Publication date: April 1, 2000

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more